Biotech Stock News (ATRA) (ARRY) (AZN)

Atara Biotherapeutics (NASDAQ:ATRA) On Monday December 14, 2015 shares of Atara Biotherapeutics tanked 37% after the company reported that a phase 2 trial in patients with kidney disease failed to produce statistically significant results. The patients in the trial had kidney disease, but had a problem with protein energy Wasting — PEW. The phase 2 … Read more